Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Res Int ; 2019: 9068314, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31143777

RESUMO

BACKGROUND: Malar melasma has a chronic and recurrent character that may be related to epigenetic changes. OBJECTIVE: To recognize the expression and DNA methylation of DNA methyltransferases (DNMTs) in malar melasma and perilesional skin, as well as the changes in DNMTs after their treatment with sunscreen in combination with 4% niacinamide, 0.05% retinoic acid, or placebo. METHODS: Thirty female patients were clinically evaluated for the expression of DNMT1 and DNMT3b using real-time PCR and immunofluorescence. These initial results were compared to results after eight weeks of treatment with sunscreen in combination with niacinamide, retinoic acid, or placebo. RESULTS: The relative expression of DNMT1 was significantly elevated in melasma compared with unaffected skin in all subjects, indicating DNA hypermethylation. After treatment, it was decreased in all groups: niacinamide (7 versus 1; p<0.01), retinoic acid (7 versus 2; p<0.05), and placebo (7 versus 3; p<0.05), which correlates with clinical improvement. DNMT3b was not overexpressed in lesional skin but reduced in all groups. CONCLUSIONS: We found DNA hypermethylation in melasma lesions. Environmental factors such as solar radiation may induce cellular changes that trigger hyperpigmentation through the activation of pathways regulated by epigenetic modifications. However, limiting or decreasing DNA methylation through sunscreen, niacinamide, and retinoic acid treatments that provide photoprotection and genetic transcription can counteract this.


Assuntos
Metilases de Modificação do DNA/metabolismo , Melanose/tratamento farmacológico , Melanose/enzimologia , Niacinamida/uso terapêutico , Protetores Solares/uso terapêutico , Tretinoína/uso terapêutico , 5-Metilcitosina/metabolismo , Adulto , Metilação de DNA , Metilases de Modificação do DNA/genética , Epiderme/efeitos dos fármacos , Epiderme/patologia , Feminino , Fluorescência , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Humanos , Placebos , Protetores Solares/farmacologia
2.
Am J Dermatopathol ; 37(10): 761-6, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26381025

RESUMO

The pathogenesis of melasma, a common, photo-induced hyperpigmentary disorder, is not clearly understood. Significant factors linked to melasma are ultraviolet radiation exposure and genetic predisposition. Histological analysis has demonstrated that melasma is caused by a network of cellular interactions among melanocytes, keratinocytes, mast cells, fibroblasts, and dermal vasculature exhibits, features similar to chronic sun damage. Dermal inflammation caused by ultraviolet radiation might play an important role in the hyperpigmentation and reactivation of melasma lesions through the production of melanogenic cytokines and growth factors. Because the role of inflammation in this disorder is unknown, we used histochemistry, immunohistochemistry, and quantitative real-time polymerase chain reaction to evaluate melasma lesions from healthy female patients (n = 20) with malar melasma. Lesional skin without specific solar exposure or photoprotection measures within the previous 4 weeks was compared with nonlesional skin. The increased lymphocytic infiltrate in lesional skin was mainly composed of CD4 T cells, mast cells, and macrophages. Levels of the cytokine interleukin (IL)-17 and the proinflammatory mediator cyclooxygenase (COX)-2 were significantly elevated in affected skin compared with healthy skin. In addition, the Melasma Activity and Severity Index score, fraction of solar elastosis, and epidermal melanin were positively associated with COX-2 expression. There was no statistically significant difference in IL-1α, IL-1ß, R-IL1, IL-6, IL-8, vascular endothelial growth factor, and tumor necrosis factor alpha expression levels. Together, these data indicated that melasma under unchallenged conditions is characterized by chronic inflammatory cells and mediators, which may explain its recurrent nature.


Assuntos
Antígenos CD4/análise , Ciclo-Oxigenase 2/análise , Dermatite/imunologia , Mediadores da Inflamação/análise , Interleucina-17/análise , Melanose/imunologia , Pele/imunologia , Imunidade Adaptativa , Adulto , Doenças Assintomáticas , Biomarcadores/análise , Estudos de Casos e Controles , Ciclo-Oxigenase 2/genética , Dermatite/enzimologia , Dermatite/genética , Dermatite/patologia , Feminino , Humanos , Imunidade Inata , Imuno-Histoquímica , Interleucina-17/genética , Melanose/enzimologia , Melanose/genética , Melanose/patologia , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Pele/enzimologia , Pele/patologia , Regulação para Cima
3.
Crit Rev Food Sci Nutr ; 55(14): 1992-2003, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25584522

RESUMO

Undesirable enzymatic browning mediated by polyphenol oxidase (E.C. 1.14.18.1) on the surface of seafood from crustaceans have been a great concern to food processors, causing quality losses of seafood products. Seafoods especially from crustaceans are worldwide consumed due to their delicacy and nutritional value. However, black spot formation (melanosis) is the major problem occurring in crustaceans during postmortem handling and refrigerated storage induce deleterious changes in organoleptic properties and, therefore, decreases commercial value. Polyphenoloxidase (PPO), the copper-containing metalloprotein involved in oxidation of phenol to quinone is the major biochemical reaction of melanosis formation. This enzymatic mechanism causes unappealing blackening in postharvest crustaceans. To alleviate the melanosis formation in crustaceans, use of phenolic compounds from plant extract can serve as antimelanotics and appears to be a good alternative to the conventional sulfites which are associated with health-related disorders. In this review, we focuses on the unique features about the structure, distribution, and properties of PPO as well as mechanism of melanosis formation and provide a comprehensive deeper insight on the factors affecting melanosis formation and its inhibition by various antimelanotics including newly discovered plant phenolic compounds.


Assuntos
Catecol Oxidase/efeitos dos fármacos , Crustáceos/enzimologia , Manipulação de Alimentos/métodos , Fenóis/farmacologia , Extratos Vegetais/farmacologia , Frutos do Mar , Animais , Catecol Oxidase/química , Armazenamento de Alimentos , Melanose/enzimologia , Melanose/prevenção & controle , Oxirredução/efeitos dos fármacos , Refrigeração
5.
J Dermatol ; 36(1): 10-6, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19207431

RESUMO

Activation of the inducible nitric oxide synthase (iNOS)/nitric oxide (NO) pathway in keratinocytes has been reported to be associated with the pathogenesis of melanogenesis. Akt activation plays an important role in the activation of the transcription factor nuclear factor (NF)-kappaB and subsequent elevation of iNOS expression. In the present study, we highly detected both iNOS protein and Akt phosphorylation in keratinocytes of the basal layer of the epidermis at the junction with the dermis of melasma skin biopsy specimens, but not in normal skin tissues, from nine patients using immunohistological analysis. iNOS protein and phosphorylated Akt were co-localized in the lesional skins, and their levels were highly correlated R2= 0.69). Furthermore, iNOS mRNA was also detected in an additional three skin biopsy specimens, but not in normal skin, by reverse transcription polymerase chain reaction. Our results describe that iNOS expression is elevated in human melasma lesions, probably via activation of the Akt/NF-kappaB pathway, indicating that NO production plays an important role in the mechanism of hyperpigmentation in human facial melasma.


Assuntos
Melanose/enzimologia , Óxido Nítrico Sintase Tipo II/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Adulto , Sequência de Bases , Primers do DNA/genética , Feminino , Humanos , Masculino , Melanose/genética , Melanose/patologia , Pessoa de Meia-Idade , Óxido Nítrico Sintase Tipo II/genética , Fosforilação , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Pele/enzimologia , Pele/patologia
6.
Curr Eye Res ; 22(5): 348-52, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11600935

RESUMO

PURPOSE: Mitomycin C has been used in the treatment of primary acquired melanosis and melanomas of the conjunctiva. Because there is increasing evidence that NAD(P)H:quinone oxidoreductase (EC 1.6.99.2, NQO1) or DT-diaphorase plays an important role in the bioactivation of mitomycin C, we examined pathologic specimens of these tumors for NQO1 by immunohistochemistry. METHODS: Formalin-fixed, paraffin-embedded sections with histologic diagnoses of primary acquired melanosis or conjunctival melanomas were obtained from the Eye Pathology Laboratory, University of Colorado Health Sciences Center. Detection of NQO1 in tissues was performed using standard immunohistochemical techniques with monoclonal antibodies against NQO1 and immunoperoxidase staining. Samples were examined by two independent reviewers and NQO1 staining was graded from 0 (no staining) to 3+ (intense staining). RESULTS: Eleven of 11 melanomas (95% confidence interval, 72% to 100%) and three of three lesions with primary acquired melanosis with atypia stained positively for NQO1. In the melanomas, staining was relatively uniform, while in primary acquired melanosis there was cell-to-cell variability in the staining. CONCLUSIONS: NQO1 was detected by immunohistochemistry in every examined section of primary acquired melanosis and melanoma of the conjunctiva, suggesting that NQO1 may play a role in the bioactivation of mitomycin C in these tumors.


Assuntos
Neoplasias da Túnica Conjuntiva/enzimologia , Melanoma/enzimologia , Melanose/enzimologia , NAD(P)H Desidrogenase (Quinona)/metabolismo , Anticorpos Monoclonais , Humanos , Técnicas Imunoenzimáticas
7.
J Pathol ; 115(4): 199-205, 1975 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1159566

RESUMO

Colonic biopsies from six patients with normal colons and seven patients with melanosis coli were studied ultrastructurally and histochemically for lysosomal enzymes. Anthraquinone purgatives were found to increase the number of macrophages in the connective tissue of the colonic mucosa. In addition, they cause an increase in the intensity of lysosomal activity and an increase in the number of lysosomes in macrophages, Schwann cells and neurones of the submucosal plexus of the colonic mucosa.


Assuntos
Antraquinonas/efeitos adversos , Catárticos/efeitos adversos , Doenças do Colo/induzido quimicamente , Melanose/induzido quimicamente , Adulto , Idoso , Biópsia , Colo/patologia , Colo/ultraestrutura , Doenças do Colo/enzimologia , Doenças do Colo/patologia , Feminino , Humanos , Lisossomos/efeitos dos fármacos , Lisossomos/enzimologia , Macrófagos/ultraestrutura , Melanose/enzimologia , Melanose/patologia , Pessoa de Meia-Idade , Neurônios/ultraestrutura , Células de Schwann/ultraestrutura , Plexo Submucoso/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...